Cambridge Investment Research Advisors Inc. Sells 1,776 Shares of Innovator IBD 50 ETF (NYSEARCA:FFTY)

Cambridge Investment Research Advisors Inc. lessened its position in Innovator IBD 50 ETF (NYSEARCA:FFTY – Get Rating) by 6.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 27,524 shares of the company’s stock after selling 1,776 shares during the quarter. Cambridge Investment Research Advisors Inc. owned about 0.80% of Innovator IBD 50 ETF worth $601,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Royal Bank of Canada lifted its position in shares of Innovator IBD 50 ETF by 409.3% during the 3rd quarter. Royal Bank of Canada now owns 52,101 shares of the company’s stock worth $1,273,000 after purchasing an additional 41,872 shares during the last quarter. Sowell Financial Services LLC boosted its position in shares of Innovator IBD 50 ETF by 67.7% in the third quarter. Sowell Financial Services LLC now owns 46,701 shares of the company’s stock valued at $1,141,000 after acquiring an additional 18,860 shares during the period. UBS Group AG grew its stake in shares of Innovator IBD 50 ETF by 6.8% in the first quarter. UBS Group AG now owns 36,561 shares of the company’s stock worth $1,429,000 after acquiring an additional 2,328 shares during the last quarter. National Bank of Canada FI increased its position in Innovator IBD 50 ETF by 5.4% during the fourth quarter. National Bank of Canada FI now owns 31,074 shares of the company’s stock worth $675,000 after acquiring an additional 1,595 shares during the period. Finally, Tower Research Capital LLC TRC raised its stake in Innovator IBD 50 ETF by 25.5% during the 3rd quarter. Tower Research Capital LLC TRC now owns 29,725 shares of the company’s stock valued at $727,000 after purchasing an additional 6,042 shares during the last quarter.

Innovator IBD 50 ETF Price Performance

Shares of Innovator IBD 50 ETF stock opened at $22.95 on Wednesday. The firm has a fifty day moving average price of $23.18 and a two-hundred day moving average price of $23.43. Innovator IBD 50 ETF has a fifty-two week low of $21.43 and a fifty-two week high of $34.15. The company has a market cap of $78.04 million, a PE ratio of 10.61 and a beta of 1.14.

Innovator IBD 50 ETF Company Profile

(Get Rating)

The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is managed by Innovator.